IRCT201101293468N5
Completed
Phase 2
Evaluation of different doses of midazolam for amnesia and sedation in general anesthesia
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- amnesia.
- Sponsor
- Shahid Sadoughi University of Medical Sciences and Health Services
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria: 1\- ASA Class\=1,2; 2\- Elective outpatient surgical procedure under general anesthesia; 3\- age below 60 years; 4\- weight between 50\-100 kilogram; 5\- No visual disturbance; 6\- No auditory disturbance; 7\- No memory disturbance; 8\- No tranqulizer drug consumption. Exclusion criteria: known allergy to study drug.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A comparative study on the usefulness of midazolam and pethidine in esophagogastroduodenoscopyPatients requiring upper gastrointestinal endoscopyJPRN-UMIN000022087St. Marianna University School of Medicine32
Completed
Phase 3
Comparison of low dose midazolam and etomidate for the Prevention of myoclonic Movements following etomidate Injection.Myoclonic Movements.IRCT20160307026950N6Esfahan University of Medical Sciences120
Not yet recruiting
Not Applicable
clinical trial to compare two different drugs, midazolam and dexmedetomidine to reduce high blood pressure in patients undergoing cataract surgeryHealth Condition 1: O- Medical and SurgicalCTRI/2023/05/053071Dr Ashwini H
Not yet recruiting
Phase 3
The effect ofmidazolam and anxiety on amnesiaanxiety.Generalized anxiety disorderF41.1IRCT20200213046484N1Iran University of Medical Sciences120
Completed
Phase 4
se of midazolam in different doses to prevent muscle movements caused by etomidateHealth Condition 1: null- Surgery under general anaesthesiaCTRI/2017/11/010382niversity College of Medical Sciences and GTB Hospital164